Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Parkinson's Disease

  Free Subscription


Articles published in Rev Neurol

Retrieve available abstracts of 32 articles:
HTML format



Single Articles


    May 2021
  1. ALONSO-CANOVAS A, Martinez-Castrillo JC
    [Apomorphine: a powerful ally in Parkinson's disease].
    Rev Neurol. 2021;72:323-332.
    PubMed     Abstract available


    April 2021
  2. GONZALEZ-CASTRO A, Rodriguez-Rodriguez E, Arnaiz F, Ferrer-Pargada D, et al
    [Peripheral facial paralysis in patients with SARS-CoV-2 in prono position].
    Rev Neurol. 2021;72:296-297.
    PubMed    


  3. MUNOZ-SALGADO M, Del Rio D
    [Object and action naming in a sentence context in people with Parkinson's disease free of dementia].
    Rev Neurol. 2021;72:223-230.
    PubMed     Abstract available


    March 2021
  4. MANEZ-MIRO JU, Vivancos-Matellano F, Wetmore J, Martinez-Martin P, et al
    [Pilot study of a new tool to optimise dopaminergic treatment in Parkinson's disease: the OPTIMIPARK questionnaire].
    Rev Neurol. 2021;72:179-186.
    PubMed     Abstract available


  5. AGUILAR-AGUDO A, Herruzo-Cabrera J, Pino-Osuna MJ
    [Protective and risk factors predicting caregiver psychological distress in people with advanced Parkinson's disease].
    Rev Neurol. 2021;72:145-150.
    PubMed     Abstract available


    January 2021
  6. MELENDEZ-FLORES JD, Castillo-Torres SA, Cerda-Contreras C, Chavez-Luevanos B, et al
    Clinical features of metabolic syndrome in patients with Parkinson's disease.
    Rev Neurol. 2021;72:9-15.
    PubMed     Abstract available


  7. AVILA A, Pastor P, Planellas L, Gil-Villar MP, et al
    [DISCREPA study: treatment of advanced Parkinson's disease and use of second-line treatments in Catalonia].
    Rev Neurol. 2021;72:1-8.
    PubMed     Abstract available


    December 2020
  8. BRANDIN-DE LA CRUZ N, Secorro N, Calvo S, Benyoucef Y, et al
    Immersive virtual reality and antigravity treadmill training for gait rehabilitation in Parkinson's disease: a pilot and feasibility study.
    Rev Neurol. 2020;71:447-454.
    PubMed     Abstract available


  9. RODRIGUEZ-SANZ A, Pena-Llamas E, Alonso-Canovas A, Alonso-Frech FA, et al
    [Clinical experience in the treatment of motor fluctuations in Parkinson's disease. Delphi consensus of a group of experts in movement disorders].
    Rev Neurol. 2020;71:407-420.
    PubMed     Abstract available


    June 2020
  10. LINAZASORO-CRISTOBAL G, Lopez Del Val LJ, Garcia Ruiz-Espiga P, Lopez-Manzanares L, et al
    Optimized clinical management of Parkinson's disease with opicapone. Recommendations from Spanish experts.
    Rev Neurol. 2020;70.
    PubMed     Abstract available


  11. CHIARAMONTE R, Bonfiglio M
    Acoustic analysis of voice in Parkinson's disease: a systematic review of voice disability and meta-analysis of studies.
    Rev Neurol. 2020;70:393-405.
    PubMed     Abstract available


    March 2020
  12. MILLER KJ, Suarez-Iglesias D, Seijo-Martinez M, Ayan C, et al
    Physiotherapy for freezing of gait in Parkinson's disease: a systematic review and meta-analysis.
    Rev Neurol. 2020;70:161-170.
    PubMed     Abstract available


    November 2019
  13. SILVA DDO, Correa JCF, de Sa MAF, Normando VMF, et al
    Validation and reproducibility of the Glittre activities of daily living test for individuals with Parkinson's disease.
    Rev Neurol. 2019;69:395-401.
    PubMed     Abstract available


    May 2019
  14. FERNANDEZ-SOTOS P, Lopez-Arcas Calleja P, Lozano-Vicario L, Garcia-Tercero E, et al
    [Posterior reversible leukoencephalopathy syndrome in a patient with Parkinson's disease and initial psychiatric symptoms: a complex clinical presentation].
    Rev Neurol. 2019;68:426-430.
    PubMed     Abstract available


    August 2018
  15. CAMPO-ARIAS A, Castillo-Tamara EE, Herazo E
    [Review of cases of zoophilia in patients with Parkinson's disease].
    Rev Neurol. 2018;67:129-132.
    PubMed     Abstract available


    July 2018
  16. FERNANDEZ-PAJARIN G, Ares-Pensado B, Sesar A, Iglesias-Canle J, et al
    [Outpatient establishment and initial management of treatment with intraduodenal levodopa-carbidopa infusion in advanced Parkinson's disease].
    Rev Neurol. 2018;67:1-5.
    PubMed     Abstract available


    May 2018
  17. CANCELA JM, Nascimento CM, Varela S, Seijo-Martinez M, et al
    Influence of cognitive impairment on the freezing of gait in non demented people with Parkinson's disease.
    Rev Neurol. 2018;66:289-296.
    PubMed     Abstract available


    February 2018
  18. BENITO-LEON J
    [Epidemiology of Parkinson's disease in Spain and its contextualisation in the world].
    Rev Neurol. 2018;66:125-134.
    PubMed     Abstract available


  19. MORALES-GOMEZ S, Elizagaray-Garcia I, Yepes-Rojas O, de la Puente-Ranea L, et al
    [Effectiveness of virtual immersion programmes in patients with Parkinson's disease. A systematic review].
    Rev Neurol. 2018;66:69-80.
    PubMed     Abstract available


    January 2018
  20. GARCIA-RUIZ PJ, Feliz-Feliz CE, Maycas-Cepeda T, Del Val-Fernandez J, et al
    [Amimia in Parkinson's disease. Significance and correlation with the clinical features].
    Rev Neurol. 2018;66:45-48.
    PubMed     Abstract available


  21. TORRES CV, Lopez-Manzanares L, Navas-Garcia M, Pastor J, et al
    [Bilateral two-stage implantation for deep brain stimulation in the treatment of bilateral idiopathic Parkinson's disease: clinical outcomes].
    Rev Neurol. 2018;66:1-6.
    PubMed     Abstract available


    December 2017
  22. TABERNERO ME, Musich F, Cossini FC, Politis DG, et al
    [Social cognition in Parkinson's disease dementia and behavioral variant of frontotemporal dementia].
    Rev Neurol. 2017;65:539-545.
    PubMed     Abstract available


    November 2017
  23. DE YEBENES JG
    [Cervantes and Parkinson's disease].
    Rev Neurol. 2017;65:432.
    PubMed    


  24. DE FABREGUES O, Gironell A, Rossello-Jimenez D, Regueras E, et al
    [Movement disorders units and management of motor fluctuations in advanced Parkinson's disease].
    Rev Neurol. 2017;65:396-404.
    PubMed     Abstract available


    October 2017

  25. [Relationship between homocysteinaemia and sympathetic skin response in Parkinson's disease].
    Rev Neurol. 2017;65:348-352.
    PubMed     Abstract available


    June 2017
  26. FELIZ-FELIZ CE, Garcia-Ruiz PJ, Del Val-Fernandez J, Venegas-Perez B, et al
    [Benign late onset Parkinson's disease].
    Rev Neurol. 2017;64:575-576.
    PubMed    


    March 2017
  27. MEJIA P, Piedra LM, Merchan-Del Hierro X
    [Rapidly progressive dementia and parkinsonism associated to multiple dural arteriovenous fistulas].
    Rev Neurol. 2017;64:214-218.
    PubMed     Abstract available


    February 2017
  28. LOPEZ-VALDES JC
    [Were the Aztecs the first to represent Parkinson's disease?]
    Rev Neurol. 2017;64:143.
    PubMed    


    December 2016
  29. VIVANCOS-MATELLANO F, Garcia-Ruiz AJ, Garcia-Agua Soler N
    [Pharmacoeconomic study of the treatment of advanced Parkinson's disease].
    Rev Neurol. 2016;63:529-536.
    PubMed     Abstract available


    November 2016
  30. SEGARRA AB, Banegas I, Prieto I, Ramirez-Sanchez M, et al
    [Brain asymmetry and dopamine: beyond motor implications in Parkinson's disease and experimental hemiparkinsonism].
    Rev Neurol. 2016;63:415-421.
    PubMed     Abstract available


    October 2016
  31. DAVILA-ORTIZ DE MONTELLANO DJ, Rodriguez-Violante M, Fresan A, Monroy-Jaramillo N, et al
    [Frequency of single nucleotide polymorphisms and alpha-synuclein haplotypes associated with sporadic Parkinson's disease in the Mexican population].
    Rev Neurol. 2016;63:345-350.
    PubMed     Abstract available


    April 2016
  32. GALLARDO-ALCANIZ MJ, Cabello-De la Rosa JP, Bravo-Gomez JJ, Diaz-Gomez S, et al
    [Supra-on state freezing of gait: two case reports].
    Rev Neurol. 2016;62:357-60.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: